Ashe Carol Gail 4
4 · Elicio Therapeutics, Inc. · Filed Nov 25, 2024
Insider Transaction Report
Form 4
Ashe Carol Gail
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-11-21+4,100→ 4,100 totalExercise: $5.12Exp: 2034-11-21→ Common Stock (4,100 underlying)
Footnotes (1)
- [F1]The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.